Company news
Telo Genomics Corp. news in 2022
Telo Genomics Corp.'s news releases, calls and decks from 2022, newest first.
Telo Genomics Appoints Kris Weinberg as Chief Executive Officer
December 12, 2022
Telo Genomics Forms World-Class Multiple Myeloma Advisory Board in Preparation for the American Society of Hematology Annual Meeting
December 8, 2022
Telo Genomics Launches a Minimal Residual Disease Clinical Trial in Multiple Myeloma
November 9, 2022
Telo Genomics Engages Key Opinion Leader to Form and Chair Myeloma Advisory Board
October 18, 2022
Telo Genomics Announces Achieving Interim Results from Smouldering Myeloma Clinical Study
September 14, 2022
Telo Genomics Completes Processing of Multiple Myeloma Drug Resistance Patient Samples
August 17, 2022
Telo Genomics Launches Clinical Study of Drug Resistance Test for Multiple Myeloma
July 13, 2022
Telo Genomics Completes Processing and Analysis of Smoldering Multiple Myeloma Patient Samples
July 6, 2022
Telo Genomics Announces Successful Validation of Its Proprietary Automation Tools for Smoldering Multiple Myeloma
May 31, 2022
Telo Genomics Announces Investor Relations Agreement and Option Grants
March 15, 2022
Telo Genomics Launches Clinical Validation of its Smoldering Multiple Myeloma Diagnostic Test
March 7, 2022
Telo Genomics Appoints Dr. McGlennen as Board Director, a Leader in Commercializing Novel Diagnostic Technologies
February 3, 2022
Telo Genomics Advances Its Lead Product and Implements Automation to Its Workflow
January 19, 2022